nodes	percent_of_prediction	percent_of_DWPC	metapath
Cinacalcet—CASR—parathyroid gland—nephrolithiasis	0.285	0.346	CbGeAlD
Cinacalcet—CASR—nephron—nephrolithiasis	0.278	0.337	CbGeAlD
Cinacalcet—CASR—nephron tubule—nephrolithiasis	0.06	0.0728	CbGeAlD
Cinacalcet—CASR—renal system—nephrolithiasis	0.0545	0.0662	CbGeAlD
Cinacalcet—CASR—kidney—nephrolithiasis	0.0527	0.064	CbGeAlD
Cinacalcet—CYP1A2—urine—nephrolithiasis	0.0277	0.0336	CbGeAlD
Cinacalcet—CYP3A4—urine—nephrolithiasis	0.02	0.0243	CbGeAlD
Cinacalcet—CYP2D6—urine—nephrolithiasis	0.0197	0.0239	CbGeAlD
Cinacalcet—CASR—G alpha (i) signalling events—RGS14—nephrolithiasis	0.0105	0.136	CbGpPWpGaD
Cinacalcet—Ventricular arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00955	0.0959	CcSEcCtD
Cinacalcet—CASR—G alpha (q) signalling events—DGKH—nephrolithiasis	0.0085	0.11	CbGpPWpGaD
Cinacalcet—CASR—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.0076	0.0988	CbGpPWpGaD
Cinacalcet—CYP1A2—renal system—nephrolithiasis	0.00677	0.00822	CbGeAlD
Cinacalcet—CASR—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.00615	0.0798	CbGpPWpGaD
Cinacalcet—CASR—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.0055	0.0714	CbGpPWpGaD
Cinacalcet—Pain in extremity—Hydrochlorothiazide—nephrolithiasis	0.00513	0.0516	CcSEcCtD
Cinacalcet—Gastrointestinal haemorrhage—Hydrochlorothiazide—nephrolithiasis	0.00513	0.0516	CcSEcCtD
Cinacalcet—CYP3A4—renal system—nephrolithiasis	0.0049	0.00595	CbGeAlD
Cinacalcet—CYP2D6—renal system—nephrolithiasis	0.00482	0.00586	CbGeAlD
Cinacalcet—CYP3A4—kidney—nephrolithiasis	0.00474	0.00575	CbGeAlD
Cinacalcet—CYP2D6—kidney—nephrolithiasis	0.00466	0.00566	CbGeAlD
Cinacalcet—Cramp muscle—Hydrochlorothiazide—nephrolithiasis	0.00462	0.0464	CcSEcCtD
Cinacalcet—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.00412	0.0414	CcSEcCtD
Cinacalcet—CASR—GPCR downstream signaling—RGS14—nephrolithiasis	0.00359	0.0466	CbGpPWpGaD
Cinacalcet—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.0035	0.0351	CcSEcCtD
Cinacalcet—CASR—Signaling by GPCR—RGS14—nephrolithiasis	0.00326	0.0423	CbGpPWpGaD
Cinacalcet—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00317	0.0319	CcSEcCtD
Cinacalcet—CASR—GPCR ligand binding—CHRM3—nephrolithiasis	0.0031	0.0403	CbGpPWpGaD
Cinacalcet—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.00297	0.0298	CcSEcCtD
Cinacalcet—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00286	0.0287	CcSEcCtD
Cinacalcet—CASR—GPCR ligand binding—PTH—nephrolithiasis	0.00283	0.0368	CbGpPWpGaD
Cinacalcet—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00282	0.0284	CcSEcCtD
Cinacalcet—Cough—Hydrochlorothiazide—nephrolithiasis	0.0027	0.0271	CcSEcCtD
Cinacalcet—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00263	0.0264	CcSEcCtD
Cinacalcet—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00263	0.0264	CcSEcCtD
Cinacalcet—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00263	0.0264	CcSEcCtD
Cinacalcet—CASR—GPCR downstream signaling—DGKH—nephrolithiasis	0.00242	0.0315	CbGpPWpGaD
Cinacalcet—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.0024	0.0242	CcSEcCtD
Cinacalcet—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00236	0.0237	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.0023	0.0231	CcSEcCtD
Cinacalcet—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00226	0.0228	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—ADCY10—nephrolithiasis	0.00226	0.0294	CbGpPWpGaD
Cinacalcet—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00225	0.0226	CcSEcCtD
Cinacalcet—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00222	0.0223	CcSEcCtD
Cinacalcet—CASR—Signaling by GPCR—DGKH—nephrolithiasis	0.0022	0.0286	CbGpPWpGaD
Cinacalcet—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00219	0.022	CcSEcCtD
Cinacalcet—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00217	0.0218	CcSEcCtD
Cinacalcet—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00216	0.0217	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00206	0.0207	CcSEcCtD
Cinacalcet—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.002	0.0201	CcSEcCtD
Cinacalcet—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00199	0.02	CcSEcCtD
Cinacalcet—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00199	0.02	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—RGS14—nephrolithiasis	0.00192	0.025	CbGpPWpGaD
Cinacalcet—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00186	0.0187	CcSEcCtD
Cinacalcet—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00181	0.0182	CcSEcCtD
Cinacalcet—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00178	0.0179	CcSEcCtD
Cinacalcet—CASR—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00175	0.0228	CbGpPWpGaD
Cinacalcet—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00173	0.0173	CcSEcCtD
Cinacalcet—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00167	0.0168	CcSEcCtD
Cinacalcet—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.0016	0.0161	CcSEcCtD
Cinacalcet—CASR—GPCR downstream signaling—PTH—nephrolithiasis	0.0016	0.0208	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—CHRM3—nephrolithiasis	0.00159	0.0207	CbGpPWpGaD
Cinacalcet—Rash—Hydrochlorothiazide—nephrolithiasis	0.00159	0.016	CcSEcCtD
Cinacalcet—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00159	0.016	CcSEcCtD
Cinacalcet—Headache—Hydrochlorothiazide—nephrolithiasis	0.00158	0.0159	CcSEcCtD
Cinacalcet—Nausea—Hydrochlorothiazide—nephrolithiasis	0.0015	0.015	CcSEcCtD
Cinacalcet—CASR—Signaling by GPCR—PTH—nephrolithiasis	0.00145	0.0189	CbGpPWpGaD
Cinacalcet—CYP1A2—Phase II conjugation—SLC26A1—nephrolithiasis	0.00133	0.0173	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.0013	0.0169	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—DGKH—nephrolithiasis	0.0013	0.0169	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—CHRM3—nephrolithiasis	0.00094	0.0122	CbGpPWpGaD
Cinacalcet—CYP2D6—Biological oxidations—SLC26A1—nephrolithiasis	0.000919	0.0119	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—PTH—nephrolithiasis	0.000859	0.0112	CbGpPWpGaD
Cinacalcet—CYP1A2—Biological oxidations—SLC26A1—nephrolithiasis	0.000778	0.0101	CbGpPWpGaD
Cinacalcet—CYP3A4—Biological oxidations—SLC26A1—nephrolithiasis	0.000601	0.0078	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—SPP1—nephrolithiasis	0.000431	0.0056	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—GRHPR—nephrolithiasis	0.000207	0.00269	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—AGXT—nephrolithiasis	0.000185	0.0024	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—GRHPR—nephrolithiasis	0.000176	0.00228	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—SLC26A1—nephrolithiasis	0.000157	0.00204	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—APRT—nephrolithiasis	0.000157	0.00204	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—AGXT—nephrolithiasis	0.000157	0.00203	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—GRHPR—nephrolithiasis	0.000136	0.00176	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—APRT—nephrolithiasis	0.000133	0.00173	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—SLC26A1—nephrolithiasis	0.000133	0.00173	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—AGXT—nephrolithiasis	0.000121	0.00157	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—AQP1—nephrolithiasis	0.000112	0.00145	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—SLC26A1—nephrolithiasis	0.000103	0.00133	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—APRT—nephrolithiasis	0.000103	0.00133	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—CHRM3—nephrolithiasis	0.000101	0.00132	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—AQP1—nephrolithiasis	9.49e-05	0.00123	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—CHRM3—nephrolithiasis	8.58e-05	0.00111	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—AQP1—nephrolithiasis	7.32e-05	0.000951	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—CHRM3—nephrolithiasis	6.62e-05	0.00086	CbGpPWpGaD
